Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03826966 · ClinicalTrials.gov registry record · NA

Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App

A NA study of Opioid Use Disorder and Addiction, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT03826966 is a NA study of Opioid Use Disorder and Addiction that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 15 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03826966, a NA study of Opioid Use Disorder and Addiction, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This research is being done to find out whether an app based cognitive behavior therapy called reSET improves the adherence to and outcome of buprenorphine treatment for opioid use disorder (OUD) in the setting of a Hub and Spoke implementation system.

Interventions

  • DEVICE reSET

Study Locations (1)

Pennsylvania

  • Pennsylvania Psychiatric Institute, Opioid Treatment Program - Harrisburg

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-03-04
Est. Completion 2020-01-31
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT03826966

The ClinicalTrials.gov registry entry for NCT03826966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which reSET is the first listed.

NCT03826966 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03826966 about?

NCT03826966 is a clinical study titled "Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App". This research is being done to find out whether an app based cognitive behavior therapy called reSET improves the adherence to and outcome of buprenorphine treatment for opioid use disorder (OUD) in the setting of a Hub and Spoke implementation system.

What is the current status of trial NCT03826966?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-03-04. Estimated completion is 2020-01-31.

What conditions does trial NCT03826966 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Addiction.

What interventions are being tested in trial NCT03826966?

The interventions under investigation include: reSET (DEVICE).

Who is sponsoring clinical trial NCT03826966?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03826966 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.